Tumor necrosis factor-α production by human islets leads to postisolation cell death

Transplantation

Volumn 82, Issue 6, 2006, Pages 813-818

  Hanley, Stephen ^a,b   Liu, Shuqing ^a   Lipsett, Mark ^a,b   Castellarin, Mauro ^a,b   Rosenberg, Lawrence ^a,b   Tchervenkov, Jean ^a   Paraskevas, Steven ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Cytokines; Islet; Isolation; TNF

Indexed keywords

CYTOKINE; DEXTRO ARGINYL DEXTRO NORLEUCYL DEXTRO NORLEUCYL DEXTRO NORLEUCYL DEXTRO ARGINYL DEXTRO NORLEUCYL DEXTRO NORLEUCYL DEXTRO NORLEUCYLGLYCYL DEXTRO TYROSINAMIDE; GLUCOSE; INSULIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GENE EXPRESSION; GRAFT SURVIVAL; HUMAN; INSULIN RELEASE; MALE; PANCREAS FUNCTION; PANCREAS INJURY; PANCREAS ISLET; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; APOPTOSIS; CADAVER; CELL DEATH; CELLS, CULTURED; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INSULIN; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; PEPTIDES; TISSUE DONORS; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33749122707     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000234787.05789.23     Document Type: Article

References (40)

1. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343(4): 230.
2. Hering BJ, Kandaswamy R, Harmon JV, et al. Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody. Am J Transplant 2004; 4(3): 390.
3. Annual Report. Bethesda, MD: Collaborative Islet Transplant Registry, 2004; 1.
4. London NJ, Robertson GS, Chadwick DR, et al. Human pancreatic islet isolation and transplantation. Clin Transplant 1994; 8(5): 421.
5. Bottino R, Fernandez LA, Ricordi C, et al. Transplantation of allogeneic islets of Langerhans in the rat liver: effects of macrophage depletion on graft survival and microenvironment activation. Diabetes 1998; 47(3): 316.
6. de Haan BJ, Faas MM, de Vos P. Factors influencing insulin secretion from encapsulated islets. Cell Transplant 2003; 12(6): 617.
7. Machen J, Bertera S, Chang Y, et al. Prolongation of islet allograft survival following ex vivo transduction with adenovirus encoding a soluble type 1 TNF receptor-Ig fusion decoy. Gene Ther 2004; 11(20): 1506.
8. Aikin R, Maysinger D, Rosenberg L. Cross-talk between phosphatidylinositol 3-kinase/AKT and c-jun NH2-terminal kinase mediates survival of isolated human islets. Endocrinology 2004; 145(10): 4522.
9. Matsuda T, Omori K, Vuong T, et al. Inhibition of p38 pathway suppresses human islet production of pro-inflammatory cytokines and improves islet graft function. Am J Transplant 2005; 5(3): 484.
10. Arita S, Nagai T, Ochiai M, et al. Prevention of primary nonfunction of canine islet autografts by treatment with pravastatin. Transplantation 2002; 73(1): 7.
11. Nagata M, Mullen Y, Matsuo S, et al. Destruction of islet isografts by severe nonspecific inflammation. Transplant Proc 1990; 22(2): 855.
12. Berney T, Molano RD, Cattan P, et al. Endotoxin-mediated delayed islet graft function is associated with increased intra-islet cytokine production and islet cell apoptosis. Transplantation 2001; 71(1): 125.
13. Gysemans C, Stoffels K, Giulietti A, et al. Prevention of primary nonfunction of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents. Diabetologia 2003; 46(8): 1115.
14. Gysemans CA, Waer M, Valckx D, et al. Early graft failure of xenogeneic islets in NOD mice is accompanied by high levels of interleukin-1 and low levels of transforming growth factor-beta mRNA in the grafts. Diabetes 2000; 49(12): 1992.
15. Movahedi B, Van de Casteele M, Caluwe N, et al. Human pancreatic duct cells can produce tumour necrosis factor-alpha that damages neighbouring beta cells and activates dendritic cells. Diabetologia 2004; 47(6): 998.
16. Paraskevas S, Maysinger D, Wang R, et al. Cell loss in isolated human islets occurs by apoptosis. Pancreas 2000; 20(3): 270.
17. Vargas F, Vives-Pi M, Somoza N, et al. Endotoxin contamination may be responsible for the unexplained failure of human pancreatic islet transplantation. Transplantation 1998; 65(5): 722.
18. Li L, El-Kholy W, Rhodes CJ, Brubaker PL. Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B. Diabetologia 2005.
19. Ou D, Wang X, Metzger DL, et al. Synergistic inhibition of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human pancreatic beta cells by Bcl-2 and X-linked inhibitor of apoptosis. Hum Immunol 2005; 66(3): 274.
20. Choi SE, Choi KM, Yoon IH, et al. IL-6 protects pancreatic islet beta cells from pro-inflammatory cytokines-induced cell death and functional impairment in vitro and in vivo. Transpl Immunol 2004; 13(1): 43.
21. Chang I, Kim S, Kim JY, et al. Nuclear factor kappaB protects pancreatic beta-cells from tumor necrosis factor-alpha-mediated apoptosis. Diabetes 2003; 52(5): 1169.
22. Han X, Sun Y, Scott S, Bleich D. Tissue inhibitor of metalloproteinase-1 prevents cytokine-mediated dysfunction and cytotoxicity in pancreatic islets and beta-cells. Diabetes 2001; 50(5): 1047.
23. Aikin R, Rosenberg L, Maysinger D. Phosphatidylinositol 3-kinase signaling to Akt mediates survival in isolated canine islets of Langerhans. Biochem Biophys Res Commun 2000; 277(2): 455.
24. Rabinovitch A, Suarez-Pinzon W, Strynadka K, et al. Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. Diabetes 1999; 48(6): 1223.
25. Lakey JR, Warnock GL, Shapiro AM, et al. Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant 1999; 8(3): 285.
26. Ricordi C, Lacy PE, Finke EH, et al. Automated method for isolation of human pancreatic islets. Diabetes 1988; 37(4): 413.
27. Ricordi C, Gray DW, Hering BJ, et al. Islet isolation assessment in man and large animals. Acta Diabetol Lat 1990; 27(3): 185.
28. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248.
29. Downs TR, Wilfinger WW. Fluorometric quantification of DNA in cells and tissue. Anal Biochem 1983; 131(2): 538.
30. Arnush M, Heitmeier MR, Scarim AL, et al. IL-1 produced and released endogenously within human islets inhibits beta cell function. J Clin Invest 1998; 102(3): 516.
31. Wang H, Lee SS, Gao W, et al. Donor treatment with carbon monoxide can yield islet allograft survival and tolerance. Diabetes 2005; 54(5): 1400.
32. Delaney CA, Pavlovic D, Hoorens A, et al. Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinology 1997; 138(6): 2610.
33. Meldrum DR, Cain BS, Cleveland JC Jr., et al. Adenosine decreases post-ischaemic cardiac TNF-alpha production: anti-inflammatory implications for preconditioning and transplantation. Immunology 1997; 92(4): 472.
34. Meldrum DR, Shames BD, Meng X, et al. Nitric oxide downregulates lung macrophage inflammatory cytokine production. Ann Thorac Surg 1998; 66(2): 313.
35. Toyama H, Takada M, Suzuki Y, Kuroda Y. Activation of macrophage-associated molecules after brain death in islets. Cell Transplant 2003; 12(1): 27.
36. Wu Y, Han B, Luo H, et al. DcR3/TR6 effectively prevents islet primary nonfunction after transplantation. Diabetes 2003; 52(9): 2279.
37. Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005; 293(7): 830.
38. Kim WH, Lee JW, Gao B, Jung MH. Synergistic activation of JNK/SAPK induced by TNF-alpha and IFN-gamma: Apoptosis of pancreatic beta-cells via the p53 and ROS pathway. Cell Signal 2005; 17(12): 1516.
39. Matsumoto S. Clinical application of perfluorocarbons for organ preservation. Artif Cells Blood Substit Immobil Biotechnol 2005; 33(1): 75.
40. van der Burg MP, Graham JM. Iodixanol density gradient preparation in university of wisconsin solution for porcine islet purification. Scientific World J 2003; 3: 1154.